ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA,…
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA,…
HANGZHOU, China, Sept. 30, 2021 (GLOBE NEWSWIRE) — Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology…
VANCOUVER, British Columbia, Sept. 29, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP. (CSE: TO)…
GAITHERSBURG, Md., Sept. 29, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
WOBURN, Mass., Sept. 29, 2021 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL;…
Collaborative research utilized insights gained from CENTOGENE’s rare disease-centric Bio/Databank to help analyze data of…
SAN DIEGO, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE”…
REDWOOD CITY, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — It is with profound sadness that…
GENFIT Reports First Half-Year 2021 Financial Results and Provides Corporate Update Financial highlights Cash and…
COPENHAGEN, Denmark, Sept. 29, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
EMERYVILLE, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage…
ANAHEIM, CA, Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Management board of the joint stock company “Olainfarm”, registration No 40003007246, registered address: Rūpnīcu iela…
Guerbet contributes to the NH TherAguix IPO on Euronext Growth, a specialist in innovative biotechnologies…
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
Sandusky, OH, Sept. 29, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) has…
The project will engage the community to build the definitive reference set of the human…
Lomecel-B significantly decreased biomarker Tie-2 in Aging Frailty subjects at 270 days compared to placebo…
Company honored at 6th Annual Massachusetts Legislative Manufacturing Caucus Awards ceremony LAUPHEIM, Germany and MILFORD,…